Additional information
White Powder
1795135-61-3
ACI-062103
N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethylamino ethylphenylacetamide
N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]acetamide
154.5-156.8ºC
C20H26N2O4
358.43
Ambient
2-8°C
N-[2-Hydroxy-5-[1-hydroxy-2-[[2-(4- methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]acetamide
long-acting beta agonists (LABAs)





![BUTOXYQUINOLINONE BREXPIPRAZOLE (25 mg) (7-[4-(7-{4-[4-(Benzo[b]thiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2-yloxy)butoxy]quinolin-2(1H)-one)](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)